Fig. 1From: Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategyReactivity percentage of nasopharyngeal and saliva based rapid diagnostic testing kits among several group populationsBack to article page